10 apr: Tre effektive måder at reducere din formue på
12 apr: Minimalistisk pragtvilla i Sverige
11-04-2012 23:21:00

Quest Diagnostics Names Rusckowski As President, CEO

Relateret indhold

DOW JONES NEWSWIRES

Quest Diagnostics Inc. (DGX) named Royal Philips Electronics NV (PHG, PHIA.AE) executive Stephen Rusckowski as its new president and chief executive, ending a six-month search for a successor to current CEO Surya Mohapatra.

Rusckowski's appointment is effective May 1 and he will also join the company's board. Rusckowski has served as CEO of Philips Healthcare, Royal Philips' largest unit, since 2006.

The management change could mark a new course for the company. Some decisions Quest made under Mohapatra--such as the acquisition of diagnostics company AmeriPath Inc. and an expansion into India--have been criticized by analysts.

Quest, the largest diagnostic-testing company in the U.S. by revenue, had been hurt by a decline in doctor-office visits as consumers have reined in their health-care spending since the recession. Last year, the company unveiled a restructuring initiative to reduce its costs by $500 million over the next three years to help it meet profit targets. In October, the company initiated a search for a replacement for Mohapatra, who held the titles of chairman, president and CEO.

Quest also appointed lead director Daniel C. Stanzione as its new non-executive chairman.

"Steve Rusckowski is uniquely qualified to be chief executive officer of Quest Diagnostics," Stanzione said. "He has built an enviable track record in health care by successfully driving growth, both organically and through disciplined, effective acquisitions. His emphasis on operational excellence has enabled him to deliver consistently impressive results."

In January, Quest reported its fourth-quarter earnings rose 14% as the company saw higher testing revenue and improved margins.

Shares closed at $59.57 Wednesday and were unchanged after hours. The stock is up 2.6% since the start of the year.

-By Nathalie Tadena, Dow Jones Newswires; 212-416-3287; nathalie.tadena@dowjones.com

(END) Dow Jones Newswires

April 11, 2012 17:21 ET (21:21 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Vestas vinder mølleordre i USA

21-02-2018 13:57:11
Vestas har fået en ordre på 50 megawatt (MW) i USA. Ordren er på V136-3,45 MW-møllen, der er optimeret til 3,6 MW.Den mølletype har siden oktober 2017 givet Vestas en samlet ordreindgang i USA på mere end 900 MW.Det oplyser Vestas i en meddelelse.Kontrakten med kunden, der har ønsket at være anonym, omfatter levering og installation samt idriftsættelse af møllerne, og der er også en flerårig servi..

Vestas henter italiensk ordre på 57 MW - NY

21-02-2018 11:18:47
Vestas har modtaget en bestilling på vindmøller med en samlet kapacitet på 57 megawatt (MW) til et projekt i Italien.Kunden er energiselskabet E.On.Det fremgår af en meddelelse onsdag formiddag.Ordren omfatter 19 styk V112-3,0 MW-møller, og kontrakten er resultatet af et udbud over italienske vindmølleprojekter, og det såkaldte Morcone-projekt, som møllerne skal bruges til, bliver et af de største..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Mærsk/Sydbank: Aktionærer kan se frem til udbetaling i 2018 eller 2019
2
Aktier/tendens: Vestas, Genmab og Mærsk kan komme i fokus
3
Genmab/Sydbank: Stærk Darzalex-prognose bør sende aktien op
4
Vestas vinder mølleordre i USA
5
Genmab: Darzalex-salget i USA steg med 6,2 pct. i januar

Relaterede aktiekurser

Quest Diagnostics Incorp.. 101,91 0,0% Aktiekurs uændret
Philips KON 31,37 0,0% Aktiekurs uændret

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2018  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
22. februar 2018 08:01:54
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: LiveBranchBuild_20180219.1 - EUROWEB6 - 2018-02-22 08:01:54 - 2018-02-22 08:01:54 - 1 - Website: OKAY